Clinical Trials Directory

Trials / Conditions / Parkinson's Disease Psychosis

Parkinson's Disease Psychosis

9 registered clinical trials studyying Parkinson's Disease Psychosis — 2 currently recruiting.

StatusTrialSponsorPhase
CompletedA Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
NCT06068465
Tasly Pharmaceutical Group Co., LtdPhase 3
RecruitingPimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
NCT04373317
VA Office of Research and DevelopmentPhase 4
RecruitingComparing Antipsychotic Medications in LBD Over Time
NCT05590637
The University of Texas Health Science Center at San AntonioPhase 4
CompletedA Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
NCT01174004
ACADIA Pharmaceuticals Inc.Phase 3
CompletedA Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
NCT00658567
ACADIA Pharmaceuticals Inc.Phase 3
CompletedA Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosi
NCT00550238
ACADIA Pharmaceuticals Inc.Phase 3
CompletedA Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
NCT00477672
ACADIA Pharmaceuticals Inc.Phase 3
CompletedAn Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
NCT01518309
ACADIA Pharmaceuticals Inc.Phase 2
Approved For MarketingExpanded Access of Pimavanserin for Patients With PD Psychosis
NCT02762591
ACADIA Pharmaceuticals Inc.—